Enpro (NPO) Q4 2025 earnings summary

Executive summary

• Achieved 9% sales growth to $1.14 billion in 2025, with organic sales up 7.6%, driven by aerospace, food, biopharma, and semiconductor markets.

• Adjusted diluted EPS rose 13.6% to $7.91, and adjusted EBITDA margin held steady at 24.3% despite increased growth investments.

• Free cash flow increased 18% to $153.1M, supporting reinvestment in organic growth and strategic M&A.

• Completed acquisitions of AlpHa, Overlook, and AMI, contributing to growth and segment performance.

• GAAP net loss of $32.0M due to a $67.2M non-cash pension settlement; best-ever safety statistics in 2025 with a recordable incident rate of 0.64.

Financial highlights

• Full-year 2025 sales reached $1,143.3M, up from $1,048.7M in 2024.

• Fourth quarter sales increased 14.3% to $295.4M; organic sales up 10%.

• Adjusted EBITDA for Q4 rose 19.2% to $69.4M; margin up 100 bps to 23.5%.

• Adjusted diluted EPS for Q4 was $1.99, up 26.8% year-over-year.

• Free cash flow for 2025 was $153.1M, up 18% from 2024.

Outlook and guidance

• 2026 sales growth expected at 8%-12%, including $60M from recent acquisitions.

• 2026 Adjusted EBITDA guidance: $305M-$320M; Adjusted EPS: $8.50-$9.20.

• CapEx for 2026 projected at $50M (~4% of sales), focused on growth investments.

• Focus on organic growth and strategic acquisitions, leveraging strong cash flow and balance sheet.

• Sealing Technologies and AST segments expect margin expansion and stronger second half in 2026.